At the end of the latest market close, Vyant Bio Inc. (VYNT) was valued at $2.88. In that particular session, Stock kicked-off at the price of $2.88 while reaching the peak value of $3.42 and lowest value recorded on the day was $2.86. The stock current value is $3.33.
Recently in News on May 13, 2021, Vyant Bio Announces Investor Conference Call and Webcast for First Quarter 2021. Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is focused on integrating human-powered scientific and technology-based systems to de-risk and accelerate the discovery and development of preclinical and clinical pipelines for biopharma partners as well as for the proprietary pipeline of the Company. Today, Vyant Bio announced that an investor conference call and webcast will be hosted on Tuesday, May 18, 2021. You can read further details here
Vyant Bio Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $17.50 on 02/10/21, with the lowest value was $2.78 for the same time period, recorded on 05/11/21.
Vyant Bio Inc. (VYNT) full year performance was 13.27%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Vyant Bio Inc. shares are logging -80.97% during the 52-week period from high price, and 58.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.11 and $17.50.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1361383 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Vyant Bio Inc. (VYNT) recorded performance in the market was 20.22%, having the revenues showcasing -50.45% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 31.70M, as it employees total of 40 workers.
Specialists analysis on Vyant Bio Inc. (VYNT)
During the last month, 0 analysts gave the Vyant Bio Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.45, with a change in the price was noted +0.63. In a similar fashion, Vyant Bio Inc. posted a movement of +23.33% for the period of last 100 days, recording 1,815,829 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for VYNT is recording 0.03 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.03.
Trends and Technical analysis: Vyant Bio Inc. (VYNT)
Raw Stochastic average of Vyant Bio Inc. in the period of last 50 days is set at 11.70%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 28.72%. In the last 20 days, the company’s Stochastic %K was 14.45% and its Stochastic %D was recorded 11.55%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 20.22%. Additionally, trading for the stock in the period of the last six months notably improved by 50.00%, alongside a boost of 13.27% for the period of the last 12 months. The shares increased approximately by 2.46% in the 7-day charts and went up by -8.52% in the period of the last 30 days. Common stock shares were lifted by -50.45% during last recorded quarter.